ADAP
Adaptimmune Therapeutics
ADAP
ADAP
79 hedge funds and large institutions have $67M invested in Adaptimmune Therapeutics in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 14 closing their positions.
Holders
79
Holders Change
-1
Holders Change %
-1.25%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
14
Increased
19
Reduced
21
Closed
14
Calls
$24K
Puts
$9K
Net Calls
+$15K
Net Calls Change
-$86K